15 October 2024
EMBL Hamburg scientists have gained molecular insights into how we absorb vitamin B1 – a mechanism with implications for disease and drug development.
SCIENCE & TECHNOLOGY
6 June 2024
The group of Christian Löw at EMBL Hamburg and CSSB, and collaborators from the Christian-Albrechts-University Kiel and CNRS & Université Paris Cité worked together to reveal the structure and function of a previously unknown lysosome transporter, MFSD1.
SCIENCE & TECHNOLOGY
3 November 2021
Scientists at EMBL Hamburg determined the molecular structure of Peptide Transporters 1 and 2. The findings will enable developing drugs that more efficiently pass from the gut to target tissues.
SCIENCE & TECHNOLOGY
2021
sciencescience-technology
30 March 2021
Scientists at EMBL Hamburg use droplets of protein solution to grow protein crystals. By exposing the crystals to X-rays, they are able to determine the protein’s molecular structure.
SCIENCE & TECHNOLOGY
2021
picture-of-the-weekscience-technology
4 November 2020
By screening hundreds of sybodies (synthetic mini-antibodies), scientists have identified one that might stop SARS-CoV-2 from infecting human cells. This work, which holds promise for treating COVID-19, was conducted by EMBL Hamburg and collaborators from the Centre for Structural Systems Biology…
SCIENCE & TECHNOLOGY
2020
sciencescience-technology
13 October 2020
A group of scientists led by EMBL Hamburg’s Christian Löw provide insights into the molecular structure of proteins involved in the gliding movements through which the parasites causing malaria and toxoplasmosis invade human cells.
SCIENCE & TECHNOLOGY
2020
sciencescience-technology
28 April 2020
Scientists at EMBL Hamburg and Karolinska Institutet Stockholm aim to find synthetic antibodies – known as nanobodies – that bind a surface protein of the novel SARS-CoV-2 coronavirus. Nanobodies could prevent the virus from entering human cells and causing COVID-19.
SCIENCE & TECHNOLOGY
2020
sciencescience-technology
No results found